Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 58533-15-6 | MDL No. : | MFCD00769822 |
Formula : | C9H9ClN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 180.63 g/mol | Pubchem ID : | 3744796 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 50.81 |
TPSA : | 17.82 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.48 cm/s |
Log Po/w (iLOGP) : | 2.15 |
Log Po/w (XLOGP3) : | 2.7 |
Log Po/w (WLOGP) : | 2.71 |
Log Po/w (MLOGP) : | 2.21 |
Log Po/w (SILICOS-IT) : | 2.38 |
Consensus Log Po/w : | 2.43 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.15 |
Solubility : | 0.128 mg/ml ; 0.000708 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.73 |
Solubility : | 0.339 mg/ml ; 0.00187 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.49 |
Solubility : | 0.0582 mg/ml ; 0.000322 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.5 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0℃; for 1 h; Stage #2: at 20℃; |
General procedure: 2-Chloro-1H-benzoimidazole (3.04 g, 20 mmol) was dissolved in dry DMF (15 mL) at 0 °C, to the solution was added NaH (0.91 g, 22.7 mmol), and the mixture was stirred for 1 h at 0 °C, then halide (21.6 mmol) was added. The mixture was stirred overnight at room temperature and was poured into water (50 mL) and stirred for 1 h, filtrated, washed with water and dried to afford 4a-d. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | With NaH In N,N-dimethyl-formamide; mineral oil | Step 1) Preparation of 2-Chloro-1-ethylbenzimidazole To a cooled (0° C.) stirred suspension of NaH (60percent dispersion in mineral oil; 7.08 g, 0.118 mol) in DMF (100 mL) was added 2-chlorobenzimidazole (15.00 g, 0.098 mol). The mixture was warmed to room temperature and stirred for 1 hour. Ethyl iodide (18.40 g, 0.118 mol) was added and stirring was continued for 3 hours. The mixture was poured onto the ice water and the resulting off-white solid was collected by filtration to give 10.0 g (61percent) of product m.p. 48°-50° C. NMR (DMSO-d6, 300 MHz): δ1.3 (t, J=8.6 Hz, 3H), 4.28 (q, J=8.6 Hz, 2H), 7.25 (m, 2H), 7.60 (m, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
77% | With hydrogenchloride In dichloromethane; trichlorophosphate | A. 2-chloro-1-ethylbenzimidazole 1-Ethyl-2-benzimidazolinone (100 g, 0.62 mol) was dissolved in phosphorus oxychloride (475 mL) with stirring and heated to reflux temperature. Hydrogen chloride gas was passed into the refluxing solution for 4 h. Excess phosphorous oxychloride was removed on a rotary evaporator at 70° C. The residue was poured into a stirred mixture of aqueous potassium carbonate solution and methylene chloride. The mixture was basified with 50percent sodium hydroxide solution and the methylene chloride layer was separated, dried (Na2 SO4), concentrated, and distilled to obtain 86 g (77percent) of oil, bp 110°-115° C./2-0.3 mmHg, which crystallized on standing; mp 50°-52° C. |
[ 3705-87-1 ]
2-Chloro-1-isopropyl-1H-benzo[d]imidazole
Similarity: 0.96
[ 40019-65-6 ]
2-(2-Chloro-1H-benzo[d]imidazol-1-yl)ethanol
Similarity: 0.93
[ 43181-78-8 ]
1-Benzyl-2-chloro-1H-benzo[d]imidazole
Similarity: 0.89
[ 87233-54-3 ]
2-Chloro-1-(2-ethoxyethyl)-1H-benzo[d]imidazole
Similarity: 0.86
[ 1849-02-1 ]
2-Chloro-1-methyl-1H-benzo[d]imidazole
Similarity: 0.86
[ 3705-87-1 ]
2-Chloro-1-isopropyl-1H-benzo[d]imidazole
Similarity: 0.96
[ 40019-65-6 ]
2-(2-Chloro-1H-benzo[d]imidazol-1-yl)ethanol
Similarity: 0.93
[ 43181-78-8 ]
1-Benzyl-2-chloro-1H-benzo[d]imidazole
Similarity: 0.89
[ 87233-54-3 ]
2-Chloro-1-(2-ethoxyethyl)-1H-benzo[d]imidazole
Similarity: 0.86
[ 1849-02-1 ]
2-Chloro-1-methyl-1H-benzo[d]imidazole
Similarity: 0.86